EurekAlert! -
5 Jun 2016 06:00
(NYU Langone Medical Center / New York University School of Medicine) A new drug that harnesses the immune system to attack tumors is highly effective against advanced bladder cancer, according to the results of an international clinical trial to be presented June 5 at the annual meeting of the American Society for Clinical Oncology (ASCO).
Share this Article